Home | Back to newsletter main page

Bookmark and Share
Case Comprehensive Cancer Center Newsletter

September 10, 2012

CASE CCC IN THE NEWS

Study: PCa screening reduces advanced cancer risk
ModernMedicine-Sep 5, 2012
... of developing advanced cancer, which is associated with additional treatment-related costs and morbidity," said first author Jay P. Ciezki, MD.


FUNDING OPPORTUNITIES

American Cancer Society

The American Cancer Society is accepting applications for the following funding opportunities:

  • Area of Special Interest: The Role of Healthcare and Insurance in Improving Outcomes in Cancer Prevention, Early Detection and Treatment: The ACS invites applications that investigate the impact of healthcare costs, healthcare system and capacity, insurance status, social factors and delivery of health care services, on outcomes in cancer prevention, early detection and treatment. The purpose of these awards is to stimulate research on the effects of the US healthcare system structure and the role of insurance on access to screenings and treatment. Of particular interest is research using linked databases such as SEER, Medicare payment data, State data and NCHS data or other existing databases. Studies may be at the state, multi-state, or national levels, or otherwise involve large populations. Respondents should specifically describe how their results will generalize to the broader corresponding U.S. populations.
    Deadline: October 15
  • RFA: Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families: In an effort to support clinician investigators conducting patient-oriented research in palliative care, the ACS, in parallel with the National Palliative Care Research Center, is soliciting applications for pilot/exploratory research grants in palliative care of cancer patients and their families. These grants will generate the pilot data necessary to maximize an investigator's chances of competing successfully for larger grants. This RFA provides funding for investigators performing pilot and exploratory research studies whose purpose is to test interventions, develop research methodologies, and explore novel areas of research in palliative care of cancer patients and their families. A condition of funding is a clearly defined plan as to how the investigator will use the results of the project to develop larger, extramurally funded research projects.
    Deadline: October 15
  • Priority Focus in Cancer Control and Prevention Research Program: Health Disparities Research: The ACS is committed to reducing cancer health disparities and has created strategic priorities for eliminating such disparities through research, education, advocacy and service. The ACS has set as a Nationwide Objective the goal of eliminating disparities in cancer burdens by 2015. Towards this goal, the Extramural Research and Training Grants (EG) Department has made the reduction of cancer health disparities a priority area of focus for the Cancer Control and Prevention Research Program with a call for applications in psychosocial and behavioral research and in health policy and health services research that address cancer health disparities. Within the Cancer Control and Prevention Research Program (one of five research programs in the EG department), meritorious applications focusing on disparity reduction will be funded prior to meritorious applications focusing on other areas in cancer control and prevention research. In order to qualify for the Priority Program, the application must explicitly demonstrate its relevance to cancer disparities and specify how the results of the proposed study can be used to reduce disparities.
    Deadline: October 15
Alex's Lemonade Stand Foundation Springboard Grant Program

Alex's Lemonade Stand Foundation Springboard Grant is designed to support new NIH R01 or P01 research projects which were scored less than or equal to the 20th percentile but were not funded. ALSF will support projects via this mechanism for a maximum of 12 months. If NIH funding is secured and begins before the end of this 12 month period, ALSF must be notified and will cease its financial support of the project. Projects funded via this mechanism that do not receive funding from the NIH within 12 months are not eligible to reapply for the ALSF Springboard Grant.

Deadline: October 29


ANNOUNCEMENTS

Clinical Assay Development Program

The NCI Clinical Assay Development Program (CADP) is accepting applications from investigators seeking clinical assay validation resources. These resources are designed to assist with the development of assays that may predict therapy response or prognostic behavior of a diagnosed cancer, primarily for use in clinical trials. Approved projects for the NCI CADP will be provided access to the Institute's assay development and validation resources, including project management support.

When applying to the CADP, it is important that investigators define the intended clinical use for the assays for which support is requested. Assays submitted for CADP development services should have been tested on human tissue.

Deadline: October 15


NCI CANCER BULLETIN

September 4, 2012

News
Featured Article: Genome Study Points to Treatments for High-Risk Form of Childhood Leukemia

High Breast Density Does Not Predict Death among Breast Cancer Patients

Flavored Cigar Use Common among Young Adult Cigar Smokers

Gene in Stem Cell Donors May Decrease Relapse Risk in Leukemia Patients

Sequencing "Outlier" Genome Suggests Some Patients May Benefit from Cancer Drug

Researchers Use Gene Deletions to Find Cancer Treatment Targets

Also in the News: CDC Updates Hepatitis C Testing Recommendations

Also in the Journals: Youth Tobacco Use Dropped between 2000 and 2011

Commentary
A Conversation with Dr. Louis Staudt about Targeting New Treatments for Burkitt Lymphoma

In Depth
Clinical Pathways in Cancer Care Catching On

Featured Clinical Trial: Targeting Invasive Glioma Cells

Updates

FDA Update

Cancer.gov Update

Notes

EVENTS

calendar

September 10

Pathology Research Seminar Series
Trever Bivona, MD, PhD
Assistant Professor, Hematology and Oncology
University of California, San Francisco
Topic: Genome-wide Approaches to Optimize Molecularly-targeted Cancer Therapy
12 pm WRB 1-413

Physiology and Biophysics Seminar
Sharon Campbell, PhD
Professor, Biochemistry and Biophysics
University of North Carolina
Topic: Ubiquitin and Redox-mediated Posttranslational Modification of Ras Regulates Ras Activity
4 pm SOM / Robbins Building, E-501

Skeletal Research Center Weekly Seminar Series
Patrick Leahy, PhD
Assistant Professor, Div. of General Medical Sciences-Oncology
Director, Laser Capture Microdissection Service, Gene Expression and Genotyping Facility
CWRU
AND
Nicholas Beckloff, PhD
Instructor, Genetics
Director, Genomics Core Facility
CWRU
Topic: Introduction to the Deep Sequencing Capability at Case Western
4 pm Millis 123


September 11

Pharmacology Invited Seminar
Anthony Wynshaw-Boris, MD, PhD
Professor, Human Genetics and Pediatrics
Chief, Div. of Medical Genetics
University of California, San Francisco
Topic: Modeling Human Neurogenetic Disorders- From Pathogenesis to Therapies
1 pm Webster Conference Rm, W331


September 12

Hematology and Oncology Division Research Conference
Panos Savvides, MD, PhD
Assistant Professor, Div. of Hem/Onc
CWRU/UH
Topic: Head and Neck Cancer
8 am Lerner Tower B-151

Immunology Invited Speaker Seminar Series
Richard Ransohoff, MD
Director, Neuroinflammation Research Center
Cleveland Clinic
Topic: Telling Monocytes from Microglia in the Inflamed Brain: How, Why and What was Learned
12 pm NC1-202 Cleveland Clinic


September 13

Stem Cell Biology and Regenerative Medicine
Damien Reynaud, PhD
Postdoctoral Fellow, Eli and Edythe Broad Center of Regeneration Medicine
University of California, San Francisco
Topic: Cell Hierarchy and Differentiation Pathways Defining Leukemic Hematopoiesis
1 pm NE1-205


September 14

Taussig Cancer Institute Grand Rounds will resume in September

Hematology/Oncology Fellows Conference/Curriculum Series
Topic: TBD
8 am Wearn 137

Cancer Center Seminar Series
Justin Lathia, PhD
Assistant Professor, Cell Biology
CWRU/Cleveland Clinic
Topic: Holding on to Stemness: Maintenance of the Glioblastoma Cellular Hierarchy by Microenvironmental Adhesion Mechanisms
12 pm Frohring Auditorium – BRB 105

Cancer Center Research in Progress
David Askew, PhD
Senior Research Associate, Cooke Lab, Pediatrics- Hem/Onc
Topic: A Novel Role for Cdk5 in T Cell Activation and Migration During Graft-Versus-Host Reactions Following Allogeneic BMT
4 pm WRB 3-136

 

 

Case CCC Calendar

LRI Calendar


UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS

Imaging Solutions in Cancer Management: A Case-based Conference
September 21
Wolstein Research Building
Brochure
Registration

National GvHD Health Symposium
November 2
Embassy Suites Cleveland-Rockside
Details
Registration

ADDITIONAL UPCOMING SEMINARS & EVENTS

NCI Office of Cancer Centers Learning Series Webinar: Complementary and Alternative Medicine Cancer Research and the National Cancer Institute
September 11
2-3:30 pm
Registration

Ninth International Conference of the Society for Integrative Oncology
October 8-10
Albuquerque, NM
Details

Biennial Science of Global Prostate Cancer Disparities conference
November 1-4
Nassau, The Bahamas
Details

The Cancer Genome Atlas 2nd Annual Scientific Symposium: Enabling Cancer Research Through TCGA
November 27-28
Crystal City, Virginia
Details
Deadline to submit abstracts: October 5

American Society of Hematology (ASH) Annual Meeting
December 8-11
Atlanta, Georgia
Details

Pacific Symposium on Biocomputing 2013
January 3-7, 2013
Fairmont Orchid, Hawaii
Details


PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES

Komen for the Cure Challenge Grants- Investigator-Initiated Research Grants
Pre-Application Deadline: September 10
Full Application Deadline: December 17

Komen for the Cure Challenge Grants- Career Catalyst Research Grants
Pre-Application Deadline: September 10
Full Application Deadline: December 17

Komen for the Cure Investigator-Initiated Research Grants
Pre-Application Deadline: September 10
Full Application Deadline: December 17

Komen for the Cure Career Catalyst Research Grants
Pre-Application Deadline: September 10
Full Application Deadline: December 17

Pezcoller Foundation-AACR International Award for Cancer Research
Deadline: September 12

Prevent Cancer Foundation Research Grant and Fellowship
Deadline: September 14

Limited Submission: NSF Partnerships for Innovation
Internal LOI Deadline: September 14
External Deadline: December 12

Leukemia & Lymphoma Society Scholar Award
LOI Deadline: September 15
Full Application Deadline: October 1

Leukemia & Lymphoma Society Scholar in Clinical Research Award
LOI Deadline: September 15
Full Application Deadline: October 1

Leukemia & Lymphoma Society Special Fellow Award
LOI Deadline: September 15
Full Application Deadline: October 1

Leukemia & Lymphoma Society Special Fellow in Clinical Research Award
LOI Deadline: September 15
Full Application Deadline: October 1

Leukemia & Lymphoma Society Fellow Award
LOI Deadline: September 15
Full Application Deadline: October 1

Leukemia & Lymphoma Society Quality of Life Research Funding Initiative Award
LOI Deadline: September 15
Full Application Deadline: October 1

Alex's Lemonade Stand Foundation 'A' Award
Deadline: September 17

Robert Wood Johnson Foundation Health & Society Scholars program
Deadline: September 21

Szent-Györgyi Prize for Progress in Cancer Research
Deadline: September 30

Bonnie J. Addario Lung Cancer Foundation Research Grants
Deadline: October 15

Robert Wood Johnson Foundation Scholars in Health Policy Research program
Deadline: October 16

CTSC KL2 Training Program
Deadline: October 22

AACR–American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention
Nomination Deadline: September 26

AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
Nomination Deadline: September 26

AACR Award for Lifetime Achievement in Cancer Research
Nomination Deadline: September 26

AACR Princess Takamatsu Memorial Lectureship
Nomination Deadline: September 26

AACR Award for Outstanding Achievement in Chemistry in Cancer Research
Nomination Deadline: October 3

AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship
Nomination Deadline: October 3

AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship
Nomination Deadline: October 3

Melanoma Research Alliance-Prostate Cancer Foundation Team Science Partnership Award
Deadline: October 15

Alex's Lemonade Stand Foundation Epidemiology Awards
Deadline: December 17

Translational Technology Concept Studies of Circulating Tumor and Endothelial Cells (CTC/CEC)
Deadline: Open

AACR Scholar-in-Training Awards - Other Conferences and Meetings
Deadline: Open

Case CCC Protocol Specific Research Support (PSRS)
Deadline: Open

International Union Against Cancer (UICC) International Cancer Technology Transfer Fellowships
Application Deadline: Open

International Waldenstrom's Macroglobulinemia Foundation (IWMF) Research Grant Program
Application Deadline: Open

SAIC-Frederick Support of the Cancer Genome Atlas Program
Application Deadline: Open

Solving Kids' Cancer Therapeutic Development Initiative
Application Deadline: Open

NCI Short-Term Scientist Exchange Program
Application Deadline: Open


NIH BULLETIN – Notices and Funding Opportunities

NCI is Participating in PA-12-271, Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01) (NOT-CA-12-015)

Produced by:
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
216.844.8317 phone
216.844.7832 fax
gillian.irwin@case.edu

HELP US HELP YOU!

If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!

Send items to gillian.irwin@case.edu.